Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 1
2007 3
2008 1
2009 3
2010 2
2011 3
2012 2
2015 1
2016 2
2017 4
2018 1
2019 1
2020 1
2021 3
2022 3
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

33 results

Results by year

Filters applied: . Clear all
Page 1
Perioperative Durvalumab for Resectable Non-Small-Cell Lung Cancer.
Heymach JV, Harpole D, Mitsudomi T, Taube JM, Galffy G, Hochmair M, Winder T, Zukov R, Garbaos G, Gao S, Kuroda H, Ostoros G, Tran TV, You J, Lee KY, Antonuzzo L, Papai-Szekely Z, Akamatsu H, Biswas B, Spira A, Crawford J, Le HT, Aperghis M, Doherty GJ, Mann H, Fouad TM, Reck M; AEGEAN Investigators. Heymach JV, et al. N Engl J Med. 2023 Nov 2;389(18):1672-1684. doi: 10.1056/NEJMoa2304875. Epub 2023 Oct 23. N Engl J Med. 2023. PMID: 37870974 Clinical Trial.
Randomized, Double-Blind, Phase III Study of Fosnetupitant Versus Fosaprepitant for Prevention of Highly Emetogenic Chemotherapy-Induced Nausea and Vomiting: CONSOLE.
Hata A, Okamoto I, Inui N, Okada M, Morise M, Akiyoshi K, Takeda M, Watanabe Y, Sugawara S, Shinagawa N, Kubota K, Saeki T, Tamura T. Hata A, et al. Among authors: watanabe y. J Clin Oncol. 2022 Jan 10;40(2):180-188. doi: 10.1200/JCO.21.01315. Epub 2021 Nov 18. J Clin Oncol. 2022. PMID: 34793245 Free PMC article. Clinical Trial.
A phase II study (WJOG12819L) to assess the efficacy of osimertinib in patients with EGFR mutation-positive NSCLC in whom systemic disease (T790M-negative) progressed after treatment with first- or second-generation EGFR TKIs and platinum-based chemotherapy.
Takeda M, Shimokawa M, Nakamura A, Nosaki K, Watanabe Y, Kato T, Hayakawa D, Tanaka H, Takahashi T, Oki M, Tachihara M, Fujimoto D, Hayashi H, Yamaguchi K, Yamamoto S, Iwama E, Azuma K, Hasegawa K, Yamamoto N, Nakagawa K. Takeda M, et al. Among authors: watanabe y. Lung Cancer. 2023 Mar;177:44-50. doi: 10.1016/j.lungcan.2023.01.011. Epub 2023 Jan 28. Lung Cancer. 2023. PMID: 36731290 Free article. Clinical Trial.
Advanced Lung Adenocarcinoma with Nivolumab-associated Dermatomyositis.
Kudo F, Watanabe Y, Iwai Y, Miwa C, Nagai Y, Ota H, Yabe H, Demitsu T, Hagiwara K, Koyama N, Koyama S. Kudo F, et al. Among authors: watanabe y. Intern Med. 2018 Aug 1;57(15):2217-2221. doi: 10.2169/internalmedicine.9381-17. Epub 2018 Mar 9. Intern Med. 2018. PMID: 29526968 Free PMC article.
Pharmacokinetics and Safety of Defibrotide in Healthy Japanese Subjects.
Umemura K, Iwaki T, Kimura T, Ogawa C, Fukuda T, Taniguchi S, Horibe K, Goto H, Yoshimura K, Watanabe Y, Nitani C, Kikuta A. Umemura K, et al. Among authors: watanabe y. Clin Pharmacol Drug Dev. 2016 Nov;5(6):548-551. doi: 10.1002/cpdd.262. Epub 2016 May 6. Clin Pharmacol Drug Dev. 2016. PMID: 27870480 Free PMC article. No abstract available.
Reproducibility of up-flow column percolation tests for contaminated soils.
Yasutaka T, Naka A, Sakanakura H, Kurosawa A, Inui T, Takeo M, Inoba S, Watanabe Y, Fujikawa T, Miura T, Miyaguchi S, Nakajou K, Sumikura M, Ito K, Tamoto S, Tatsuhara T, Chida T, Hirata K, Ohori K, Someya M, Katoh M, Umino M, Negishi M, Ito K, Kojima J, Ogawa S. Yasutaka T, et al. Among authors: watanabe y. PLoS One. 2017 Jun 5;12(6):e0178979. doi: 10.1371/journal.pone.0178979. eCollection 2017. PLoS One. 2017. PMID: 28582458 Free PMC article.
Thymic clear cell carcinoma.
Nakano T, Endo S, Tsubochi H, Nokubi M, Watanabe Y, Koyama S. Nakano T, et al. Among authors: watanabe y. Gen Thorac Cardiovasc Surg. 2010 Feb;58(2):98-100. doi: 10.1007/s11748-009-0481-6. Epub 2010 Feb 13. Gen Thorac Cardiovasc Surg. 2010. PMID: 20155348
Exploratory Analysis Comparing Fosnetupitant Versus Fosaprepitant for Prevention of Highly Emetogenic Chemotherapy-Induced Nausea and Vomiting (CINV): A Randomized, Double-Blind, Phase 3 Study (CONSOLE).
Hata A, Shiraishi Y, Inui N, Okada M, Morise M, Akiyoshi K, Takeda M, Watanabe Y, Sugawara S, Shinagawa N, Kubota K, Saeki T, Tamura T. Hata A, et al. Among authors: watanabe y. Oncol Ther. 2022 Jun;10(1):253-262. doi: 10.1007/s40487-022-00188-2. Epub 2022 Mar 4. Oncol Ther. 2022. PMID: 35246827 Free PMC article.
33 results